GeneLink, Inc. (OTCPK: GNLK.Q)
Health Care · Biotechnology · US
$—
— today · — 1Y
GeneLink, Inc. (OTCPK: GNLK.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.60K.
trading between 0.00 and 0.00.
Tweenvest scores GeneLink, Inc. across four factors: quality 5/100. Its strongest factor is quality.
GNLK.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.60K
- Revenue (TTM)
- $1.58M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -201.52
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 265.02M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $138.89 | -4.26% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.